Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Statins demonstrate a broad anti-cytomegalovirus activity in vitro in ganciclovir-susceptible and resistant strains.

Ponroy N, Taveira A, Mueller NJ, Millard AL.

J Med Virol. 2015 Jan;87(1):141-53. doi: 10.1002/jmv.23998. Epub 2014 Jun 27.

PMID:
24976258
2.

Antiviral activity of ganciclovir and artesunate towards human cytomegalovirus in astrocytoma cells.

Schnepf N, Corvo J, Pors MJ, Mazeron MC.

Antiviral Res. 2011 Feb;89(2):186-8. doi: 10.1016/j.antiviral.2010.12.002. Epub 2010 Dec 15.

PMID:
21167209
3.
4.

Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.

Tenney DJ, Yamanaka G, Voss SM, Cianci CW, Tuomari AV, Sheaffer AK, Alam M, Colonno RJ.

Antimicrob Agents Chemother. 1997 Dec;41(12):2680-5.

5.

Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.

Gerna G, Percivalle E, Baldanti F, Sarasini A, Zavattoni M, Furione M, Torsellini M, Revello MG.

New Microbiol. 1998 Jul;21(3):293-308.

PMID:
9699213
6.

Rapid detection and quantitation of ganciclovir resistance in cytomegalovirus quasispecies.

Ruiz-Carrascoso G, Romero-Gómez MP, Plaza D, Mingorance J.

J Med Virol. 2013 Jul;85(7):1250-7. doi: 10.1002/jmv.23570. Epub 2013 Apr 16.

PMID:
23592041
7.

The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.

Oiknine-Djian E, Weisblum Y, Panet A, Wong HN, Haynes RK, Wolf DG.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00288-18. doi: 10.1128/AAC.00288-18. Print 2018 Jul.

8.

Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.

Herget T, Freitag M, Morbitzer M, Kupfer R, Stamminger T, Marschall M.

Antimicrob Agents Chemother. 2004 Nov;48(11):4154-62.

9.

Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.

Scott GM, Ng HL, Morton CJ, Parker MW, Rawlinson WD.

J Gen Virol. 2005 Aug;86(Pt 8):2141-51.

PMID:
16033961
10.

PD0084430: a non-nucleoside inhibitor of human cytomegalovirus replication in vitro.

Meyer AL, Bruening EE, Dunkle WE, Booth RJ, Steinbaugh BA, Vara Prasad JV.

Antiviral Res. 2001 Dec;52(3):289-300.

PMID:
11675146
11.

Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein.

Michel D, Höhn S, Haller T, Jun D, Mertens T.

J Med Virol. 2001 Sep;65(1):70-6. Erratum in: J Med Virol 2001 Nov;65(3):629.

PMID:
11505446
12.

In vitro antiviral efficacy of the ganciclovir complexed with beta-cyclodextrin on human cytomegalovirus clinical strains.

Nicolazzi C, Venard V, Le Faou A, Finance C.

Antiviral Res. 2002 May;54(2):121-7.

PMID:
12062397
13.

Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells.

Michaelis M, Ha TA, Doerr HW, Cinatl J Jr.

Cardiovasc Res. 2008 Feb 1;77(3):544-50. Epub 2007 Nov 12.

PMID:
18006438
14.

[In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].

Otegui M, Rabella N, Labeaga R, Herrero M, Margall R, Muñoz JM, Prats G.

Rev Esp Quimioter. 2001 Jun;14(2):155-64. Spanish.

PMID:
11704769
15.

Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus.

Posthuma CC, van der Beek MT, van der Blij-de Brouwer CS, van der Heiden PL, Marijt EW, Spaan WJ, Claas EC, Nederstigt C, Vossen AC, Snijder EJ, Kroes AC.

J Clin Virol. 2011 May;51(1):25-30. doi: 10.1016/j.jcv.2011.01.015. Epub 2011 Mar 8.

PMID:
21388868
16.

Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94.

McSharry JJ, McDonough A, Olson B, Talarico C, Davis M, Biron KK.

Clin Diagn Lab Immunol. 2001 Nov;8(6):1279-81.

17.

A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains.

Prix L, Maierl J, Jahn G, Hamprecht K.

J Clin Virol. 1998 Jul 24;11(1):29-37.

PMID:
9784141
18.

Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates.

McSharry JM, Lurain NS, Drusano GL, Landay A, Manischewitz J, Nokta M, O'Gorman M, Shapiro HM, Weinberg A, Reichelderfer P, Crumpacker C.

J Clin Microbiol. 1998 Apr;36(4):958-64.

19.

In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate.

Cinatl J, Cinatl J, Weber B, Rabenau H, Gümbel HO, Chenot JF, Scholz M, Encke A, Doerr HW.

Antiviral Res. 1995 Aug;27(4):405-18.

PMID:
8540759
20.

Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene.

Martin M, Goyette N, Boivin G.

J Clin Virol. 2010 Dec;49(4):296-8. doi: 10.1016/j.jcv.2010.08.008. Epub 2010 Sep 16.

PMID:
20843736

Supplemental Content

Support Center